DMHA at a glance
DMHA is a stimulant name on pre-workout and fat burner labels. It covers two related compounds: octodrine (2-amino-6-methylheptane) and 2-amino-5-methylheptane. Octodrine started out as a medicine for the nose and airways, and its pharmacology comes from animal studies; we found no controlled trial of DMHA in people. WADA names octodrine as a stimulant prohibited in competition, and the FDA treats DMHA in supplements as an unsafe food additive.
Evidence: Animal studies, no controlled trials in people · Updated 20 November 2026
What DMHA is
DMHA stands for dimethylhexylamine. A 2018 review of octodrine notes that the name covers two forms: 2-amino-5-methylheptane, which occurs in nature, and the synthetic 2-amino-6-methylheptane. The synthetic one is octodrine, which the WADA List names as 1,5-dimethylhexylamine. The review assumes that supplements use the synthetic form, because it is cheaper to produce.
Octodrine is an old pharmaceutical. It was developed in the United States as an inhaled treatment for bronchitis and laryngitis, and it was also sold as a nasal decongestant. In Europe it was sold as part of multi-ingredient medicines. As DMAA was being phased out of supplements, octodrine came back in pre-workouts and fat burners around 2016.
Chemically, DMHA sits close to DMAA: a 2018 laboratory study calls octodrine an analogue of 1,3-DMAA. Some marketing presents DMHA as a plant extract, citing Aconitum or Kigelia species. A 2018 analysis of 15 samples of these plants found octodrine in none of them, and its tests on supplements pointed to a synthetic source.
The name on a label does not settle what a product contains. Two laboratories analysed six brands of US supplements with DMHA-type names on the label and found four different stimulants: octodrine, 1,4-DMAA, 1,3-DMAA and 1,3-DMBA. The 2018 review, describing that study, reports octodrine in only one of the six. In the plant study above, 13 supplements named octodrine on the label or website, and 4 of them contained it.
How DMHA works
Octodrine is a sympathomimetic amine: it acts on the same signalling system as adrenaline and noradrenaline. The 2018 review calls it a central nervous system stimulant and explains its effects through alpha-adrenergic receptors and the noradrenaline transporter, which clears noradrenaline from nerve junctions.
The classic pharmacology comes from animal experiments run between the 1940s and the 1970s. In dogs, octodrine raised heart rate, the force of each heartbeat and blood pressure, and it widened the airways. A 2026 study in zebrafish larvae found that low concentrations sped up the heart, while high concentrations depressed it and disrupted conduction between its chambers. Movement dropped at concentrations far below those that affected the heart.
In people, the body breaks octodrine down quickly to heptaminol, which then becomes the main compound in the blood.
Evidence
Animal studies. The 2018 review found only five relevant publications on octodrine, most of them six to seven decades old. Studies of its activity and acute toxicity were carried out in cats, rabbits, dogs and pigs. The review cites only preliminary human data. One is a 1974 study of a combination medicine containing octodrine in patients with low blood pressure; the other is a 1973 study of gut absorption of sympathomimetic drugs. Its conclusion is that octodrine’s safety on its own remains unknown, because no placebo-controlled trial exists.
We found no controlled trial of DMHA or octodrine in people and no published case report of harm linked to it (PubMed search, 20 November 2026). The review adds that the psychoactive effects and side effects of octodrine had not been studied in humans.
Side effects. What is known about side effects comes mostly from users on forums, not from studies. The review lists high blood pressure, shortness of breath and overheating, plus rapid heartbeat, tremor, anxiety and disturbed sleep. Forum users also described tolerance and withdrawal symptoms. Every Hammer Labz label with DMHA also lists caffeine or dicaffeine malate; more in our caffeine card. Talk to a doctor before using a product with DMHA if you live with raised blood pressure, heart disease or anxiety, or if you take any medication.
Amounts on labels
Six Hammer Labz labels list DMHA, either by that name or as 2-aminoisoheptane, a name the FDA gives as a synonym of DMHA. None of them states the full chemical name of either compound.
| Hammer Labz product | Name on the label | Amount | Label serving |
|---|---|---|---|
| Monster Strength (375 g Black Series) | DMHA | 300 mg | 1 scoop (15 g) |
| Lipo Shred | 2-aminoisoheptane (DMHA) hydrochloride | 250 mg | 2 capsules |
| Monster Strength (300 g) | 2-aminoisoheptane | 250 mg | 1 scoop (10 g) |
| Lion Blood | DMHA | 175 mg | 1 cap (20 ml) |
| Fury Caps | DMHA | 150 mg | 2 capsules |
| Atomic Strength | DMHA | 100 mg | 1 scoop (10 g) |
Across these six labels, DMHA appears at 100 to 300 mg per serving. Lipo Shred lists it as a hydrochloride salt.
For stimulants that are not authorised for use in people, we give the label amount and nothing more: no amounts from studies, no “typical” amounts and no conversions between compounds. Our method is on the how we review page.
Legal and anti-doping status
Status checked on 20 November 2026.
- WADA: the 2026 and 2027 Lists name octodrine (1,5-dimethylhexylamine) in class S6, stimulants, prohibited in competition. The other compound sold as DMHA, 2-amino-5-methylheptane, is not named, but class S6 prohibits all stimulants, including those it does not list. Heptaminol, the compound the body makes from octodrine, is named in the same class.
- Contamination: in a case published in 2025, an athlete’s positive test for heptaminol was traced to a supplement contaminated with octodrine. The contamination was accepted, and the athlete was still banned for nine months.
- EU, medicines: we found no entry for octodrine, DMHA or their chemical names in the European Medicines Agency’s database of medicines authorised in the EU and EEA.
- EU, food: the EU novel food catalogue has no entry for DMHA or octodrine. A missing entry does not settle an ingredient’s status.
- US: the FDA considers DMHA an unsafe food additive that does not meet the definition of a dietary ingredient, and it treats supplements containing DMHA as adulterated. It has sent warning letters to supplement companies since April 2019. Its list of other names for DMHA includes octodrine, both compounds named above and 2-aminoisoheptane.
Not for drug-tested athletes: Lion Blood, Fury Caps, Lipo Shred, both Monster Strength tubs and Atomic Strength list DMHA or 2-aminoisoheptane. Because the body turns octodrine into heptaminol, a product containing octodrine can lead to a positive test for heptaminol, as in the 2025 case above. Status differs by country and changes over time.
Found in
Hammer Labz (brand page)
- Lion Blood
- Fury Caps (our Fury Caps review)
- Lipo Shred
- Monster Strength (300 g and 375 g Black Series)
- Atomic Strength
Sources
- Product labels: Hammer Labz supplement facts panels for Lion Blood, Fury Caps, Lipo Shred, Monster Strength 300 g, Monster Strength 375 g Black Series and Atomic Strength, as listed in November 2026.
- Catalani V, Prilutskaya M, Al-Imam A, et al. (2018). Octodrine: New Questions and Challenges in Sport Supplements. Brain Sci, 8(2), 34. PMID: 29461475.
- Cohen PA, Travis JC, Keizers PHJ, et al. (2018). Four experimental stimulants found in sports and weight loss supplements: 2-amino-6-methylheptane (octodrine), 1,4-dimethylamylamine (1,4-DMAA), 1,3-dimethylamylamine (1,3-DMAA) and 1,3-dimethylbutylamine (1,3-DMBA). Clin Toxicol (Phila), 56(6), 421–426. PMID: 29115866.
- Wang M, Haider S, Chittiboyina AG, et al. (2018). 1,5-Dimethylhexylamine (octodrine) in sports and weight loss supplements: Natural constituent or synthetic chemical? J Pharm Biomed Anal, 152, 298–305. PMID: 29454882.
- Carrão-Dantas EK, Aljabasini O, Prats E, et al. (2026). Acute Octodrine (DMHA) Exposure Disrupts Cardiac Function, Locomotor Activity, and Neuronal Activity-Responsive Transcription in Zebrafish Larvae. Int J Mol Sci, 27(19), 8560. PMID: 42883807.
- Alvarez JC, Etting I (2025). Heptaminol hair testing to highlight octodrine contamination in supplements, responsible for a doping adverse analytical finding. Clin Chim Acta, 565, 120002. PMID: 39401652.
- World Anti-Doping Agency. World Anti-Doping Code International Standard: Prohibited List 2026. In force from 1 January 2026. Accessed 20 November 2026.
- World Anti-Doping Agency. World Anti-Doping Code International Standard: Prohibited List 2027. In force from 1 January 2027. Accessed 20 November 2026.
- European Medicines Agency. Article 57 product data: medicines authorised in the EU and EEA. Data file updated 12 November 2026. Accessed 20 November 2026.
- European Commission. EU Novel Food status catalogue. Catalogue data retrieved 19 November 2026.
- U.S. Food and Drug Administration. DMHA in Dietary Supplements. Content current as of 6 March 2023. Accessed 20 November 2026.
